Remarkably, a pioneering study analyzing Apo D expression in human MS lesions found that while reactive astrocytes and mature OLGs are the primary producers of this protein, its levels are markedly low in all sclerosis plaques, particularly in inactive areas. The gene discussed is APOD; the disease is myeloid sarcoma.